Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20351341rdf:typepubmed:Citationlld:pubmed
pubmed-article:20351341lifeskim:mentionsumls-concept:C0032914lld:lifeskim
pubmed-article:20351341lifeskim:mentionsumls-concept:C0037083lld:lifeskim
pubmed-article:20351341lifeskim:mentionsumls-concept:C0034787lld:lifeskim
pubmed-article:20351341lifeskim:mentionsumls-concept:C1456820lld:lifeskim
pubmed-article:20351341lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:20351341lifeskim:mentionsumls-concept:C1514758lld:lifeskim
pubmed-article:20351341lifeskim:mentionsumls-concept:C1880177lld:lifeskim
pubmed-article:20351341pubmed:issue5lld:pubmed
pubmed-article:20351341pubmed:dateCreated2010-4-15lld:pubmed
pubmed-article:20351341pubmed:abstractTextPreeclampsia is a prevalent life-threatening hypertensive disorder of pregnancy for which the pathophysiology remains largely undefined. Recently, a circulating maternal autoantibody, the angiotensin II type I (AT(1)) receptor agonistic autoantibody (AA), has emerged as a contributor to disease features. Increased circulating maternal tumor necrosis factor alpha (TNF-alpha) is also associated with the disease; however, it is unknown whether this factor directly contributes to preeclamptic symptoms. Here we report that this autoantibody increases the proinflammatory cytokine TNF-alpha in the circulation of AT(1)-AA-injected pregnant mice but not in nonpregnant mice. Coinjection of AT(1)-AA with a TNF-alpha neutralizing antibody reduced cytokine availability in AT(1)-AA-injected pregnant mice. Moreover, TNF-alpha blockade in AT(1)-AA-injected pregnant mice significantly attenuated the key features of preeclampsia. Autoantibody-induced hypertension was reduced from 131+/-4 to 110+/-4 mm Hg, and proteinuria was reduced from 212+/-25 to 155+/-23 microg of albumin per milligram of creatinine (both P<0.05). Injection of AT(1)-AA increased the serum levels of circulating soluble fms-like tyrosine kinase 1 and soluble endoglin (34.1+/-5.1, 2.4+/-0.3 ng/mL, respectively) and coinjection with the TNF-alpha blocker significantly reduced their levels (21.7+/-3.4 and 1.2+/-0.4 ng/mL, respectively). Renal damage and placental abnormalities were also decreased by TNF-alpha blockade. Lastly, the elevated circulating TNF-alpha in preeclamptic patients is significantly correlated with the AT(1)-AA bioactivity in our patient cohort. Similarly, the autoantibody, through AT(1) receptor-mediated TNF-alpha induction, contributed to increased soluble fms-like tyrosine kinase 1, soluble endoglin secretion, and increased apoptosis in cultured human villous explants. Overall, AT(1)-AA is a novel candidate that induces TNF-alpha, a cytokine that may play an important pathogenic role in preeclampsia.lld:pubmed
pubmed-article:20351341pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20351341pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20351341pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20351341pubmed:languageenglld:pubmed
pubmed-article:20351341pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20351341pubmed:citationSubsetIMlld:pubmed
pubmed-article:20351341pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20351341pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20351341pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20351341pubmed:statusMEDLINElld:pubmed
pubmed-article:20351341pubmed:monthMaylld:pubmed
pubmed-article:20351341pubmed:issn1524-4563lld:pubmed
pubmed-article:20351341pubmed:authorpubmed-author:YangXiaXlld:pubmed
pubmed-article:20351341pubmed:authorpubmed-author:KellemsRodney...lld:pubmed
pubmed-article:20351341pubmed:authorpubmed-author:BlackwellSean...lld:pubmed
pubmed-article:20351341pubmed:authorpubmed-author:HicksM JohnMJlld:pubmed
pubmed-article:20351341pubmed:authorpubmed-author:ZhangYujinYlld:pubmed
pubmed-article:20351341pubmed:authorpubmed-author:RaminSusan...lld:pubmed
pubmed-article:20351341pubmed:authorpubmed-author:IraniRoxanna...lld:pubmed
pubmed-article:20351341pubmed:authorpubmed-author:ZhouCissy...lld:pubmed
pubmed-article:20351341pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20351341pubmed:volume55lld:pubmed
pubmed-article:20351341pubmed:ownerNLMlld:pubmed
pubmed-article:20351341pubmed:authorsCompleteYlld:pubmed
pubmed-article:20351341pubmed:pagination1246-53lld:pubmed
pubmed-article:20351341pubmed:dateRevised2010-12-3lld:pubmed
pubmed-article:20351341pubmed:meshHeadingpubmed-meshheading:20351341...lld:pubmed
pubmed-article:20351341pubmed:meshHeadingpubmed-meshheading:20351341...lld:pubmed
pubmed-article:20351341pubmed:meshHeadingpubmed-meshheading:20351341...lld:pubmed
pubmed-article:20351341pubmed:meshHeadingpubmed-meshheading:20351341...lld:pubmed
pubmed-article:20351341pubmed:meshHeadingpubmed-meshheading:20351341...lld:pubmed
pubmed-article:20351341pubmed:meshHeadingpubmed-meshheading:20351341...lld:pubmed
pubmed-article:20351341pubmed:meshHeadingpubmed-meshheading:20351341...lld:pubmed
pubmed-article:20351341pubmed:meshHeadingpubmed-meshheading:20351341...lld:pubmed
pubmed-article:20351341pubmed:meshHeadingpubmed-meshheading:20351341...lld:pubmed
pubmed-article:20351341pubmed:meshHeadingpubmed-meshheading:20351341...lld:pubmed
pubmed-article:20351341pubmed:meshHeadingpubmed-meshheading:20351341...lld:pubmed
pubmed-article:20351341pubmed:meshHeadingpubmed-meshheading:20351341...lld:pubmed
pubmed-article:20351341pubmed:meshHeadingpubmed-meshheading:20351341...lld:pubmed
pubmed-article:20351341pubmed:year2010lld:pubmed
pubmed-article:20351341pubmed:articleTitleAutoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling.lld:pubmed
pubmed-article:20351341pubmed:affiliationDepartment of Biochemistry and Molecular Biology, University of Texas Houston Medical School, 6431 Fannin St, Houston, TX 77030, USA.lld:pubmed
pubmed-article:20351341pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20351341pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:20351341pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20351341lld:pubmed